WebFeb 28, 2024 · South Korea's GC Biopharma is acquiring three programs related to orphan blood disorders from Catalyst Biosciences ( NASDAQ: CBIO ). The agreement will bring to GC Biopharma programs, including ... WebApr 6, 2024 · Catalyst Biosciences GAAP EPS of -$2.87 misses by $0.01, revenue of $7.34M beats by $2.19M. SA NewsThu, Mar. 31, 2024.
Catalyst Biosciences cuts staff, changes R&D focus - BioPharma Dive
WebFeb 6, 2013 · Another recent successful pick is EDAP TMS SA, which we first mentioned as a catalyst trade pick list on January 3rd, when shares were trading the $2.10 level. Today the stock trades near $3.60 ... WebMar 29, 2024 · Japan's Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Tuesday that the U.S. Food and Drug Administration has approved a supplemental … fitche brillen
Catalyst Pharmaceutical (CPRX) Flat As Market Sinks: What You Should …
WebOct 7, 2024 · Receive our biopharma catalyst reports, material news events, our perspective and commentary on biotech stocks awaiting FDA approval and more by email and mobile alerts text the keyword “Traders” to 52736 or click on our number and enter your mobile number in the form provided. Receive Biotech Stock Notifications WebJun 12, 2024 · For instance, Sen. Bernie Sanders sent a letter in February to Catalyst, requesting justification for the $375,000 price tag. And after Jacobus' drug was approved, Sanders described it in a May 8 statement as "a victory for patients with LEMS and American taxpayers, and a blow to the greed of Big Pharma.". Catalyst defends the … WebNews. Press Releases. Research Reports. SEC Filings. ... In the latest trading session, Catalyst Pharmaceutical (CPRX) closed at $16.78, marking a -0.94% move from the previous day. fitch ebrd